INNT
TOTAL INVALIDATION PROCESSED BY THE IB
03/19/2026
Back to search
Official data from USPTO
RELIEF THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
03/20/2026
Trademark type
Combined
Nice classes
5, 35, 42
Filing date
08/03/2016
Registration date
07/03/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/17/2025
Last transaction
03/20/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CH
Examiner
LAM, HAI-LY HUYNH
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stacked wording "RELIEF THERAPEUTICS" with a stylized tree design partially set on top of the letter "R" in "RELIEF".
Holders and representatives
Holders
Relief Therapeutics Holding S.A.
Relief Therapeutics S.A.
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary productsprescription drugs for the treatment of diabetic complicationsinflammatory diseasespulmonary affectionsneurological diseasesmetabolic diseases; diagnostic products for medical usediagnostic preparations and reagents for the diagnosis of diabetic complicationsinflammatory diseasespulmonary affectionsneurological diseasesmetabolic diseases; medicinal preparations and substancesprotein supplementspeptides from synthetic sources or extracted from natural organisms for the treatment of pulmonary affectionsdiabetic complicationsneuropathiesallergiesinflammationsmall chemical molecules from synthetic or natural sources for the treatment of pulmonary affectionsdiabetic complicationsneuropathiesallergiesinflammation ; biochemical preparations for medical or veterinary usefor the treatment of diabetic complicationsinflammatory diseasespulmonary affectionsneurological diseasesmetabolic diseases; biological and chemical reagents for medical or veterinary use; biological preparations for medical usefor the treatment of diabetic complicationsinflammatory diseasespulmonary affectionsneurological diseasesmetabolic diseases; chemical preparations for medical usefor the treatment of diabetic complicationsinflammatory diseasespulmonary affectionsneurological diseasesmetabolic diseases; biotechnological preparations for medical usefor the treatment of diabetic complicationsinflammatory diseasespulmonary affectionsneurological diseasesmetabolic diseases; biotechnological products for medical useprescription drugs for the treatment of diabetic complicationsinflammatory diseasespulmonary affectionsneurological diseasesmetabolic diseases; medical diagnostic productsdiagnostic preparations and reagents for the diagnosis of diabetic complicationsinflammatory diseasespulmonary affectionsneurological diseasesmetabolic diseases; biomarkers for medicinediagnostic biomarker reagents for medical purposes
Class 35
Business consulting; project management services for others for business purposes; business consultancy services; compilation and management of computerized databases and central data files in the field of medicine; compilation of statistics; collection and systematization of data in a central file; business informationprovision of commercial information in the field of pharmaceutical products and provision of commercial information for consumers relating to medical and scientific research in the field of pharmaceutical products
Class 42
Scientific and technological servicesscientific and pharmaceutical researchtesting the efficacysafety and tolerability of pharmaceuticalspharmaceutical drug development as well as new product research and design relating thereto; industrial analysis and research services in the field of pharmaceuticalsmedical diagnostic preparationsbiotechnology; scientific research and development and medical research and development in the field of pharmaceuticalsmedical diagnostic preparations and biotechnology; research and development in the field of biotechnology; research in the fields of chemistry and biology; research in the field of biochemistry; scientific research for medical purposes; research and development in the field of diagnostic preparations; product development consulting; research and development of products; pharmaceutical research and development services; computer-aided scientific researchtesting and analysis services in the field of pharmaceuticalsmedical diagnostic preparations and biotechnology; conducting of scientific feasibility studies; scientific analyses in the field of pharmaceuticalsmedical diagnostic preparations and biotechnology; scientific researchtesting and analysis services in the field of pharmaceuticalsmedical diagnostic preparations and biotechnology; services provided by consultants in the field of scientific and industrial researchresearch and development of new therapeutic pharmaceutical preparations; preparation of reports relating to scientific research; providing scientific research information in the form of scientific reports; provision of information and data relating to scientific and technological research and development in the field of pharmaceuticalsmedical diagnostic preparations and biotechnology; providing research information and results in the fields of biotechnologyscience and medicine from an on-line searchable database; pharmaceutical drug development services; pharmaceutical research and development; scientific laboratory services; scientific research services for third parties in the field of biotechnology; design and development of computer hardware and software; development and research of products for third parties; consultancy services relating to biotechnology; analysis servicesconsulting services in the fields of biotechnologypharmacotherapy research and developmentdiagnosticspharmaceutical research and development; pharmaceutical and biological development and research services for third parties; clinical research in the field of treatment of diabetic complicationsinflammatory diseasespulmonary affectionsneurological diseasesmetabolic diseases; evaluation of pharmaceutical products; research in the field of pharmaceutical products; laboratory research in the field of medicinal and analytical chemistrybiologypharmacology and toxicology; clinical development servicesresearch and development of new therapeutic pharmaceutical preparations; none of the foregoing for clinical trials on safety and effectiveness of drugsapremilastdrugs for Behçet's diseasefor providing medical and scientific research information in the field of clinical trials
Publications
History of USPTO decisions and trademark events.
58 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/04/2026
INPC
INVALIDATION PROCESSED
03/04/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/17/2025
C71T
CANCELLED SECTION 71
01/17/2025
PRA7
REGISTERED - SEC. 7 REQUEST ABANDONED
06/01/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/03/2023
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
08/24/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/16/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/16/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/22/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/18/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/20/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/20/2022
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
01/20/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/20/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/20/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/20/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/26/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/05/2018
FIMP
FINAL DISPOSITION PROCESSED
10/05/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/03/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
07/03/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/23/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/23/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/17/2018
PUBO
PUBLISHED FOR OPPOSITION
04/17/2018
GPNX
NOTIFICATION PROCESSED BY IB
04/13/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/28/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/28/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/28/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/15/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/15/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
02/22/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/22/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
02/22/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/22/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/01/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/01/2017
GNRT
NON-FINAL ACTION E-MAILED
08/01/2017
CNRT
NON-FINAL ACTION WRITTEN
08/01/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/14/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/14/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/10/2017
RFNT
REFUSAL PROCESSED BY IB
01/27/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/10/2017
RFRR
REFUSAL PROCESSED BY MPU
01/10/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/29/2016
CNRT
NON-FINAL ACTION WRITTEN
12/28/2016
MAFR
APPLICATION FILING RECEIPT MAILED
12/27/2016
DOCK
ASSIGNED TO EXAMINER
12/23/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/23/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/22/2016
Continuous trademark protection
Get notified about every new filing that threatens RELIEF THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.